Remco Visser

2.1k citations
30 papers · 1.0k indexed · h-index 12
Topics
Monoclonal and Polyclonal Antibodies Research (16 papers)Glycosylation and Glycoproteins Research (12 papers)Galectins and Cancer Biology (7 papers)

In The Last Decade

Remco Visser

30 papers receiving 1.0k citations

Peers

Remco Visser
Comparison fields: 5 of 81
  • Radiology, Nuclear Medicine and Imaging 577
  • Molecular Biology 558
  • Immunology 496
  • Hematology 233
  • Genetics 65
Replace Z. Mishal with:
Z. Mishal France
Dzung T. Le United States
Fleur E. van de Geijn Netherlands
Zehra Kaymakcalan United States
P. Reekers Netherlands
A. Schwartz United States
Tohru Kokubo Japan
Wayne Borcherding United States
Marie‐Claire Boffa France
Ch. Marth Austria
Remco Visser relative to Z. Mishal France Z. Mishal's profile →
Citations per field
00.5×10×15×17.8×
Z. Mishal · 1×
Citations per year

Countries citing papers authored by Remco Visser

Since Specialization
Citations

This map shows the geographic impact of Remco Visser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Remco Visser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Remco Visser more than expected).

Fields of papers citing papers by Remco Visser

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Remco Visser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Remco Visser. The network helps show where Remco Visser may publish in the future.

Co-authorship network of co-authors of Remco Visser

This figure shows the co-authorship network connecting the top 25 collaborators of Remco Visser. A scholar is included among the top collaborators of Remco Visser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Remco Visser. Remco Visser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 2
3 1
4 4
5 8
6 6
7 2
8 1
9 7
10 6
11 6
12 13
13 9
14 27
15 8
16 25
17 266
18 92
19 165
20 29

About Remco Visser

Remco Visser is a scholar working on Hematology, Radiology, Nuclear Medicine and Imaging and Immunology, having authored 30 papers that have together received 1.0k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (16 papers), Glycosylation and Glycoproteins Research (12 papers) and Galectins and Cancer Biology (7 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (577 citations), Immunology (496 citations) and Hematology (233 citations). Remco Visser has collaborated with scholars based in Netherlands, United States and Germany. Frequent co-authors include Gestur Vidarsson, Manfred Wuhrer, Theo Rispens, Carolien A. M. Koeleman, Gillian Dekkers, Rosina Plomp, C. Ellen van der Schoot, Arthur E. H. Bentlage, Masja de Haas and Rick Kapur. Their work appears in journals such as Blood, The Journal of Immunology and Gastroenterology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026